U.S. panel endorses widespread use of Pfizer COVID-19 vaccine
Documents created by Pfizer for the meeting with the Food and Drug Administration advisory panel, as Pfizer seeks approval for emergency use of their COVID-19 vaccine, are seen on Thursday, Dec. 10, 2020. The meeting of outside advisers to the Food and Drug Administration represented the next-to-last hurdle before the expected start of the biggest vaccination campaign in U.S. history. Depending on how fast the FDA signs off on the panel's recommendation, shots could begin within days.
AP Photo/Jon Elswick
WASHINGTON — A U.S. government advisory panel endorsed widespread use of Pfizer’s coronavirus vaccine Thursday, putting the country just one step away from launching an epic vaccination campaign against the outbreak that has killed close to 300,000 Americans...
Become a Subscriber!
You have read all of your free articles this month. Select a plan below to start your subscription today.
Already a subscriber? Login
